Benzinga | Mar 31, 2021 07:06AM EDT

Apyx Medical Q4 EPS $(0.04) Beats $(0.11) Estimate, Sales $11.46M Beat $9.62M Estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. This is a 75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $11.46 million which beat the analyst consensus estimate of $9.62 million by 19.17 percent. This is a 36.77 percent increase over sales of $8.38 million the same period last year.